Breast cancer is the most common cancer among women in the United States, with around 297,790 new cases estimated for the year 2023. Typical symptoms of breast cancer include a lump in the breast or armpit, a change in breast size or shape, fluid coming from the nipple, and red peeling...
doi:10.1016/S0959-8049(98)80358-4Peto RClarke MCollins RDavies CGray REuropean Journal of CancerPeto R., Clarke M., Collins R. et al. Facts and figures from the meta-analyses in breast cancer. Eur J Cancer 1998; 34.
breast cancer cells have been known to enter into a state of dormancy for extended periods of time. However, the mechanisms that promote dormancy as well
Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2− early breast cancer: primary results from the Phase III NATALEE trial. Presented at the American Society of Clinical Oncology Annual Meeting; June 2, ...
Cancer registries offer an avenue to identify cancer clusters across large populations and efficiently examine potential environmental harms affecting canc
Breast cancer- Facts and Figures. This chapter first outlines the epidemiology of breast cancer around the world, looking at national and international incidence and prevalence, along with survival figures for symptomatic and screen detected breast cancers. A comparison is also made between different so...
cancer treatment, screening modalities No reporting of participant characteristics Annual vs biennial: Conducted using BCSC data linked with US SEER and other tumor registry sources; ages 40 to 85 y; >77% population non-Hispanic White DBT vs DM 3 RCTs (n = 130 196) 2 NRSIs (n ...
Breast Cancer - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional Version.
Cryoablation therapy for early-stage breast cancer: evidence and rationale. J Breast Imaging. 2023;5:646–57. Article PubMed Google Scholar Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21:S187–91. Article PubMed PubMed Central Google ...
Dysregulation of cellular metabolism is a hallmark of breast cancer progression and is associated with metastasis and therapeutic resistance. Here, we show that the breast tumor suppressor gene SIM2 promotes mitochondrial oxidative phosphorylation (OXPHO